8KK-11329-50328
6 vaccinations
2 coded responses
58 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 481 / MI
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Pfizer-BioNTech
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
-
2021-03-31
Dose 2 — Pfizer-BioNTech
- 2021-03-31
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Antibody test negative, Pre-existing disease — Feeling: GoodFree text: I am participating in a research study through (b)(6) Health System in (b)(6), MI to study the effectiveness of the vaccine. My blood was drawn after the first and second vaccines and will be drawn at months 3, 6, 9 and 12. I am a SOT liver patient on tacrolimus. The results of my blood draw at my second vaccine show that I've not developed any antibodies from the first vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-06-30
-
2021-08-31
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-03
- 2021-10-05
- 2021-10-12
- 2021-11-30
- 2022-03-01
-
2022-04-19
Dose 4 — Pfizer-BioNTech
- 2022-04-19
- 2022-04-20
- 2022-04-21
- 2022-04-22
- 2022-04-23
- 2022-04-24
- 2022-04-25
- 2022-04-26
- 2022-05-03
-
2022-05-10
Survey response — day 21, dose 4MedDRA: Medical counselling, White blood cell count decreased — Feeling: FairFree text: Low white blood cell count. Transplant team notified me after my regular bloodwork.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-17
- 2022-05-24
- 2022-05-31
- 2022-07-19
-
2022-10-06
Dose 5 — Pfizer-BioNTech
- 2022-10-18
- 2023-04-20
-
2023-05-09
Dose 6 — Pfizer-BioNTech
- 2023-05-09
- 2023-05-10
- 2023-05-11
- 2023-05-12
- 2023-05-13
- 2023-05-14
- 2023-05-15
- 2023-05-16
- 2023-05-23
- 2023-05-30
- 2023-06-06
- 2023-06-13
- 2023-06-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Pfizer-BioNTech | |
| 2 | 2021-03-31 | Pfizer-BioNTech | |
| 3 | 2021-08-31 | Pfizer-BioNTech | No |
| 4 | 2022-04-19 | Pfizer-BioNTech | No |
| 5 | 2022-10-06 | Pfizer-BioNTech | No |
| 6 | 2023-05-09 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): I am participating in a research study through (b)(6) Health System in (b)(6), MI to study the effectiveness of the vaccine. My blood was drawn after the first and second vaccines and will be drawn at months 3, 6, 9 and 12. I am a SOT liver patient on tacrolimus. The results of my blood draw at my second vaccine show that I've not developed any antibodies from the first vaccine.
redacted (b)(6)
Release 11 — day 21, dose 4
Symptoms: Low white blood cell count. Transplant team notified me after my regular bloodwork.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Medical counselling | · | · | ✓ |
| SD | White blood cell count decreased | · | · | ✓ |
| SRO | Antibody test negative | ○ | ✓ | ○ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release